The challenge
- Vaccines are the most cost effective measure to prevent the suffering caused by infectious diseases prevalent in poor countries
- New vaccine technologies have been and continue to be developed in academic and government institutions
- Commercial realities stand in the way of bringing these new technologies to the people who need them most